RALEIGH, N,C., May 1, 2023 /PRNewswire/ — The AKC Canine Health Foundation (CHF), a non-profit organization committed to advancing the health of all dogs, marks Pet Cancer Awareness Month each May to highlight the effect of its financed canine cancer research study. Already in 2023, CHF has actually granted 3 brand-new grants to study canine lymphoma, anal sac cancer, and bone cancer.
Cancer stays a significant issue for dog owners and veterinary experts. Therefore, around one quarter of CHF’s active research study portfolio is normally committed to research studies checking out more precise diagnostic tests and brand-new treatments for canine cancer. Since 1995, CHF and its donors have actually invested more than $17.7 million to study cancer at the molecular level, conduct scientific trials for brand-new treatments, and comprehend how the body immune system connects with cancer cells.
The recently granted research study grants are:
-
Grant 03144: Lomustine, Asparaginase, Procarbazine and Prednisone (LAPP) for Canine Multicentric Lymphoma: A Practical Multiagent Chemotherapy Protocol that Avoids Injectable Cytotoxics
Principal Investigator: Douglas H Thamm, VMD; Colorado State University
A scientific trial of a brand-new chemotherapy procedure utilizing drugs that do not need unique handling and for that reason might be more extensively available than presently utilized chemotherapy procedures.
-
Grant 03103: Identification of Genetic Mutations in Anal Sac Carcinoma Development in English Cocker Spaniels, Part II – Validation
Principal Investigator: Shaying Zhao, PhD; University of Georgia
Investigators will check out the hereditary anomalies that incline English Cocker Spaniels to this cancer of the anal sacs.
-
Grant 03095-A: Cell-Specific Expression of MicroRNAs in Primary and Metastatic Canine Osteosarcoma
Principal Investigator: Geoffrey Wood, DVM, PhD; University of Guelph
Investigators will figure out which cells produce an appealing canine bone cancer biomarker that might help anticipate growth habits and dog survival time.
“CHF invests greatly in research study to much better comprehend canine cancer, which is so frequently a terrible and heartbreaking illness,” says Dr. J. Charles Garvin, Chairman of the CHF Board of Directors. “In addition to assisting our dogs live longer, much healthier lives, this research study frequently supplies insight into comparable human cancers. We understand that both ends of the leash advantage when we collaborate to combat cancer, offering us more time with our precious dogs.”
These research studies belong to CHF’s $4.8 million research study portfolio of active canine cancer grants. To learn more about the Foundation’s dedication to canine cancer research study, consisting of academic resources and methods to take part in canine cancer research study, please go to akcchf.org/caninecancer.
About CHF
Since 1995, the AKC Canine Health Foundation has actually leveraged the power of science to resolve the health requirements of all dogs. With more than $67.5 million in moneying to date, the Foundation supplies grants for the greatest quality canine health research study and shares info on the discoveries that help avoid, treat and treat canine illness. The Foundation fulfills and goes beyond market requirements for financial duty, as shown by their greatest four-star Charity Navigator score and Candid Platinum Seal of Transparency. Learn more at www.akcchf.org.
View initial material: https://www.prnewswire.com/news-releases/akc-canine-health-foundation-marks-pet-cancer-awareness-month-with-three-new-canine-cancer-grants-301811739.html
SOURCE AKC Canine Health Foundation
